Ladislav Sivak (Ladislav Sivák)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Top Venues

Biomaterials science

This page only lists publications with an associated author ORCID identifier.

Publications

Marketa Charousova, Marie Kudlickova Peskova, Paulina Takacsova, Katerina Kapolkova, Yazan Haddad, Jan Bilek, Ladislav Sivak, Tomas Bartejs, Zbynek Heger, Vladimir Pekarik
Engineered human H-chain ferritin with reversed charge of the internal cavity exhibits RNA-mediated spongelike effect for loading RNA/DNA-binding molecules. Biomaterials science 12 (5) (2024)
Marketa Charousova, Marie Kudlickova Peskova, Paulina Takacsova, Katerina Kapolkova, Yazan Haddad, Jan Bilek, Ladislav Sivak, Tomas Bartejs, Zbynek Heger, Vladimir Pekarik
Engineered human H-chain ferritin with reversed charge of the internal cavity exhibits RNA-mediated spongelike effect for loading RNA/DNA-binding molecules. Biomaterials science (2024)
Marketa Charousova, Marie Kudlickova Peskova, Paulina Takacsova, Katerina Kapolkova, Yazan Haddad, Jan Bilek, Ladislav Sivak, Tomas Bartejs, Zbynek Heger, Vladimir Pekarik
Engineered human H-chain ferritin with reversed charge of the internal cavity exhibits RNA-mediated spongelike effect for loading RNA/DNA-binding molecules. Biomaterials science 12 (5) (2024)
Martin Studenovský, Anna Rumlerová, Jiřina Kovářová, Barbora Dvořáková, Ladislav Sivak, Libor Kostka, Daniel Berdár, Tomas Etrych, Marek Kovář
HPMA Copolymer Mebendazole Conjugate Allows Systemic Administration and Possesses Antitumour Activity In Vivo. Pharmaceutics 14 (6) (2022)
Jakub Tomala, Petra Weberova, Barbora Tomalova, Zuzana Jiraskova Zakostelska, Ladislav Sivak, Jirina Kovarova, Marek Kovář
IL-2/JES6-1 mAb complexes dramatically increase sensitivity to LPS through IFN-γ production by CD25 + Foxp3 - T cells. eLife 10 (2021)